How to think about stacking Semax
- Semax is an ACTH(4-7) fragment. It notably lacks the corticotropic activity of full ACTH, so it is not reported to raise cortisol — a real distinction from the parent hormone and from the older GH secretagogues.
- N-Acetyl Semax Amidate is the same molecule in a stabilised form. Combining them is a duplicate, not a stack.
- Published research is predominantly intranasal. Injection assumptions carried over from other peptides do not match the evidence base.
- No controlled trial has studied Semax combined with anything.
Combinations in detail
Russian nootropic pairing
Semax + Selank- Why it is proposed
- The canonical pairing from this research tradition: Semax reported for attention, memory consolidation and neuroprotection via BDNF/TrkB upregulation, Selank reported for anxiolysis via monoamine and GABAergic modulation. Genuinely different framings rather than two versions of one effect.
- What is reported in practice
- Reported intranasally, often on the same day with Semax earlier and Selank later, following the focus-then-calm framing.
- Cautions specific to this combination
- Both evidence bases share the same concentration in one national literature. Neither pairing nor components have independent Western replication at scale.
Sleep and recovery discussion
Semax + DSIP- Why it is proposed
- Reported as a daytime-stimulating and night-time-settling pair, on the premise that Semax's alerting framing and DSIP's sleep framing counterbalance.
- What is reported in practice
- Reported with Semax in the morning and DSIP at night.
- Cautions specific to this combination
- DSIP's own evidence base is very thin, and its sleep effects are inconsistently reported. This is a scheduling rationale rather than a mechanistic one.
What to avoid, and why
- Combining Semax with N-Acetyl Semax Amidate — the same compound in two forms.
- Assuming injection matches the evidence base; the published research is predominantly intranasal.
- Expecting cortisol effects from the ACTH lineage; the 4-7 fragment lacks corticotropic activity.
- This compound's evidence base is concentrated in Russian-language literature from a small number of research groups, with limited independent Western replication, and the published research is predominantly intranasal rather than injected. Both facts should temper how confidently any stack built on it is read.
Related reading
Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.